On December 22, 2023, SomaLogic Inc announced that independent proxy advisory firm Institutional Shareholder Services has recommended the shareholders of the Company to vote for the proposed merger with Standard BioTools at the company?s Special Meeting of Stockholders to be held on January 4, 2024. In addition, the Company recommended the shareholders to vote for the transaction and stated that the transaction with Standard BioTools delivered compelling long-term stockholder value, and the Company urged all stockholders to follow the ISS recommendation by voting for the value maximizing transaction.